News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
201,119 Results
Type
Article (14381)
Company Profile (24)
Press Release (186713)
Multimedia
Podcasts (18)
Webinars (5)
Section
Business (54537)
Career Advice (619)
Deals (10683)
Drug Delivery (34)
Drug Development (29675)
Employer Resources (70)
FDA (5222)
Job Trends (4257)
News (101282)
Policy (8938)
Tag
2027 Pharm Country Standard (1)
Academia (1086)
Academic (1)
Accelerated approval (7)
Adcomms (9)
Allergies (53)
Alliances (15122)
ALS (61)
Alzheimer's disease (521)
Antibody-drug conjugate (ADC) (64)
Approvals (5365)
Artificial intelligence (118)
Autoimmune disease (33)
Automation (8)
Bankruptcy (74)
Best Places to Work (3370)
BIOSECURE Act (6)
Biosimilars (75)
Biotechnology (11)
Bladder cancer (45)
Brain cancer (17)
Breast cancer (191)
Cancer (1276)
Cardiovascular disease (162)
Career advice (532)
Career pathing (14)
CAR-T (76)
CDC (21)
Celiac Disease (1)
Cell therapy (193)
Cervical cancer (11)
Clinical research (26384)
Collaboration (391)
Company closure (1)
Compensation (63)
Complete response letters (9)
COVID-19 (1141)
CRISPR (21)
C-suite (220)
Cystic fibrosis (29)
Data (2117)
Denatured (9)
Depression (45)
Diabetes (200)
Diagnostics (1861)
Digital health (10)
Diversity (8)
Diversity, equity & inclusion (29)
Drug discovery (56)
Drug pricing (59)
Drug shortages (17)
Duchenne muscular dystrophy (71)
Earnings (17650)
Editorial (25)
Employer branding (5)
Employer resources (65)
Events (24342)
Executive appointments (288)
FDA (6143)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (396)
Gene editing (40)
Generative AI (13)
Gene therapy (168)
GLP-1 (362)
Government (1290)
Grass and pollen (3)
Guidances (120)
Healthcare (5675)
HIV (36)
Huntington's disease (12)
IgA nephropathy (21)
Immunology and inflammation (66)
Immuno-oncology (15)
Indications (30)
Infectious disease (1229)
Inflammatory bowel disease (66)
Inflation Reduction Act (6)
Influenza (36)
Intellectual property (31)
Interviews (105)
IPO (3966)
IRA (22)
Job creations (993)
Job search strategy (455)
JPM (16)
Kidney cancer (4)
Labor market (21)
Layoffs (109)
Leadership (17)
Legal (1957)
Liver cancer (29)
Longevity (2)
Lung cancer (137)
Lymphoma (108)
Machine learning (7)
Management (23)
Manufacturing (189)
MASH (68)
Medical device (3455)
Medtech (3474)
Mergers & acquisitions (7036)
Metabolic disorders (445)
Multiple sclerosis (75)
NASH (15)
Neurodegenerative disease (81)
Neuropsychiatric disorders (20)
Neuroscience (924)
NextGen: Class of 2026 (2039)
Non-profit (1649)
Now hiring (6)
Obesity (177)
Opinion (62)
Ovarian cancer (46)
Pain (52)
Pancreatic cancer (46)
Parkinson's disease (100)
Partnered (13)
Patents (50)
Patient recruitment (117)
Peanut (19)
People (19631)
Pharmaceutical (9)
Pharmacy benefit managers (11)
Phase 1 (5892)
Phase 2 (11274)
Phase 3 (10714)
Pipeline (1416)
Policy (104)
Postmarket research (1294)
Preclinical (2137)
Press Release (30)
Prostate cancer (85)
Psychedelics (16)
Radiopharmaceuticals (77)
Rare diseases (235)
Real estate (1518)
Recruiting (23)
Regulatory (7020)
Reports (20)
Research institute (927)
Resumes & cover letters (83)
Rett syndrome (2)
RNA editing (1)
RSV (29)
Schizophrenia (45)
Series A (81)
Series B (55)
Service/supplier (2)
Sickle cell disease (25)
Special edition (3)
Spinal muscular atrophy (68)
Sponsored (10)
Startups (1258)
Stomach cancer (5)
Supply chain (25)
Tariffs (17)
The Weekly (9)
Vaccines (388)
Venture capital (22)
Weight loss (126)
Women's health (22)
Worklife (8)
Date
Last 7 days (152)
Last 30 days (481)
Last 365 days (7666)
2026 (622)
2025 (7923)
2024 (9159)
2023 (10541)
2022 (15317)
2021 (16568)
2020 (15760)
2019 (14458)
2018 (11160)
2017 (10524)
2016 (10136)
2015 (12215)
2014 (8429)
2013 (6478)
2012 (6931)
2011 (7213)
2010 (6290)
Location
Africa (273)
Alabama (11)
Alaska (4)
Arizona (64)
Arkansas (2)
Asia (13558)
Australia (2545)
California (2329)
Canada (610)
China (358)
Colorado (77)
Connecticut (80)
Delaware (99)
Europe (45553)
Florida (358)
Georgia (112)
Idaho (15)
Illinois (250)
India (23)
Indiana (149)
Iowa (4)
Japan (178)
Kansas (40)
Kentucky (14)
Louisiana (10)
Maine (12)
Maryland (371)
Massachusetts (1673)
Michigan (52)
Minnesota (142)
Missouri (35)
Montana (6)
Nebraska (7)
Nevada (33)
New Hampshire (11)
New Jersey (823)
New Mexico (7)
New York (794)
North Carolina (339)
Northern California (1105)
Ohio (76)
Oklahoma (4)
Oregon (5)
Pennsylvania (541)
Puerto Rico (4)
Rhode Island (4)
South America (397)
South Carolina (10)
Southern California (950)
Tennessee (33)
Texas (297)
United States (8972)
Utah (58)
Virginia (77)
Washington D.C. (8)
Washington State (231)
Wisconsin (21)
Wyoming (2)
201,119 Results for "celltech group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CelLBxHealth PLC Announces Board Changes
January 12, 2026
·
4 min read
Press Releases
Genflow Biosciences PLC Announces Directorate Change
January 19, 2026
·
6 min read
FDA
NK CellTech Announces FDA Clearance for Clinical Trial of NK010
On January 17, 2024 , NK CellTech Co., Ltd. (NK CellTech), a leading biotech company focused on the development of NK cellular therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of NK010, the non-genetically modified natural killer cells.
January 22, 2024
·
3 min read
Press Releases
CelLBxHealth PLC Announces Preliminary Fourth Quarter 2025 Financial Results
January 16, 2026
·
4 min read
Press Releases
Cellbxhealth PLC Announces Holding(s) in Company
December 23, 2025
·
2 min read
Press Releases
Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco
December 24, 2025
·
4 min read
Press Releases
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
December 8, 2025
·
6 min read
Press Releases
Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science
February 5, 2026
·
2 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards
October 29, 2025
·
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Signs Letter of Intent
September 23, 2025
·
4 min read
1 of 20,112
Next
